Contextlogic Inc Financial Statements From 2010 to 2025
| LOGC Stock | USD 7.61 0.02 0.26% |
Check Contextlogic Inc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Contextlogic Inc's main balance sheet or income statement drivers, such as , as well as many indicators such as . Contextlogic Inc financial statements analysis is a perfect complement when working with Contextlogic Inc Valuation or Volatility modules.
Contextlogic Inc |
Contextlogic OTC Stock Return On Asset Analysis
Contextlogic Inc's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Contextlogic Inc Return On Asset | -0.0708 |
Most of Contextlogic Inc's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Contextlogic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Contextlogic has a Return On Asset of -0.0708. This is 99.19% lower than that of the Broadline Retail sector and 99.7% lower than that of the Consumer Discretionary industry. The return on asset for all United States stocks is 49.43% lower than that of the firm.
Contextlogic Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Contextlogic Inc's current stock value. Our valuation model uses many indicators to compare Contextlogic Inc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Contextlogic Inc competition to find correlations between indicators driving Contextlogic Inc's intrinsic value. More Info.Contextlogic is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Contextlogic Inc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Contextlogic Inc's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Contextlogic Inc Financial Statements
Contextlogic Inc stakeholders use historical fundamental indicators, such as Contextlogic Inc's revenue or net income, to determine how well the company is positioned to perform in the future. Although Contextlogic Inc investors may analyze each financial statement separately, they are all interrelated. For example, changes in Contextlogic Inc's assets and liabilities are reflected in the revenues and expenses on Contextlogic Inc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Contextlogic. Please read more on our technical analysis and fundamental analysis pages.
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Logicbio Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 62 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Contextlogic Inc OTC Stock
Contextlogic Inc financial ratios help investors to determine whether Contextlogic Inc OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Contextlogic Inc with respect to the benefits of owning Contextlogic Inc security.